Tobin Speight
Nurse Practitioner · Dallas, TXNPI 1811392533
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,750 of the $34,567 with a category attached, or 86.1%. ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) accounts for 94.0% of it on its own, with 22 other manufacturers making up the rest. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 166 payments — averaging $208.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$32K
- Abiomed$278
- Novartis$254
- Kestra Medical Technology Services, Inc.$239
- Abbott$212
- Itamar Medical Inc$148
- plus $942 from 17 others
What the payments were for
- Speaking & faculty fees$29,75086%
- Food & beverage$4,80214%
- Entertainment$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 83 | $32,494 |
| Abiomed | 4 | $278 |
| Novartis | 15 | $254 |
| Kestra Medical Technology Services, Inc. | 9 | $239 |
| Abbott | 8 | $212 |
| Itamar Medical Inc | 3 | $148 |
| Boehringer Ingelheim | 6 | $133 |
| AstraZeneca | 6 | $98 |
| Alnylam Pharmaceuticals Inc. | 4 | $92 |
| Pfizer | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $80 |
| Scpharmaceuticals Inc. | 4 | $79 |
| Analog Devices Inc. | 3 | $73 |
| Daiichi Sankyo Inc. | 2 | $58 |
| Amgen | 2 | $43 |
| Lexicon Pharmaceuticals, Inc. | 2 | $36 |
| Merck | 2 | $31 |
| Edwards Lifesciences | 1 | $28 |
| Boston Scientific | 1 | $28 |
| Cvrx, Inc. | 1 | $22 |
| Invivyd Inc | 1 | $20 |
| Bayer | 1 | $17 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,567 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $14,085 |
| Bumetanide | 12 | $749 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $88 | $14,08513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Dallas
- Samantha OnealDallas$133K
- Tam TranDallas$37K
- Rachel TiuDallas$19K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.